title: Nasopharyngeal metastasis of breast carcinoma with HER 2 discordance: a case report.
authors.affiliation: Department of Otolaryngology, Alfred Health, Melbourne, Victoria, Australia.
authors.forename: Bridget
authors.initials: B
authors.lastname: Copson
authors.affiliation: Department of Otolaryngology, Alfred Health, Melbourne, Victoria, Australia.
authors.forename: Upasna
authors.initials: U
authors.lastname: Pratap
authors.affiliation: Department of Anatomical Pathology, Alfred Health, Melbourne, Victoria, Australia.
authors.forename: Catriona
authors.initials: C
authors.lastname: McLean
authors.affiliation: Department of Medical Oncology, South West Oncology, Warrnambool, Victoria, Australia.
authors.forename: Theresa
authors.initials: T
authors.lastname: Hayes
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000473:pathology* / Q000601:surgery; D000077143:Docetaxel / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008408:Mastectomy / Q000379:methods; D008875:Middle Aged; D058990:Molecular Targeted Therapy / Q000379:methods; D015508:Nasal Obstruction / Q000175:diagnosis / Q000209:etiology; D009303:Nasopharyngeal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary*; D035583:Rare Diseases; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*; D014057:Tomography, X-Ray Computed / Q000379:methods; D000068878:Trastuzumab / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000077143:Docetaxel; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab; C508053:ERBB2 protein, human; C485206:pertuzumab